Eric M Mastria
Overview
Explore the profile of Eric M Mastria including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Gupta V, Ronald J, Mastria E, Benvenuti T, Cline B, Johnson D, et al.
J Vasc Interv Radiol
. 2024 Jun;
35(10):1481-1490.
PMID: 38942284
Purpose: To determine the degree of renal function deterioration after renal cryoablation in patients with a solitary functioning kidney on the basis of ablation volume. Materials And Methods: Over a...
3.
Kelly G, Milligan J, Mastria E, Kim S, Zelenetz S, Dobbins J, et al.
J Control Release
. 2022 Jan;
343:267-276.
PMID: 35077742
Biomaterial-based approaches for a combination of radiotherapy and immunotherapy can improve outcomes in metastatic cancer through local delivery of both therapeutic modalities to the primary tumor to control local tumor...
4.
Dodd R, Scherer A, Huang W, McGivney G, Gutierrez W, Laverty E, et al.
Clin Cancer Res
. 2020 Jul;
26(18):5036-5047.
PMID: 32718998
Purpose: Nanoparticle-encapsulated drug formulations can improve responses to conventional chemotherapy by increasing drug retention within the tumor and by promoting a more effective antitumor immune response than free drug. New...
5.
Mastria E, Cai L, Kan M, Li X, Schaal J, Fiering S, et al.
J Control Release
. 2017 Nov;
269:364-373.
PMID: 29146246
Strategies that enhance the host antitumor immune response promise to revolutionize cancer therapy. Optimally mobilizing the immune system will likely require a multi-pronged approach to overcome the resistance developed by...
6.
Luginbuhl K, Schaal J, Umstead B, Mastria E, Li X, Banskota S, et al.
Nat Biomed Eng
. 2017 Oct;
1.
PMID: 29062587
Stimulation of the glucagon-like peptide-1 (GLP1) receptor is a useful treatment strategy for type 2 diabetes because of pleiotropic effects, including the regulation of islet hormones and the induction of...
7.
Mastria E, Chen M, McDaniel J, Li X, Hyun J, Dewhirst M, et al.
J Control Release
. 2015 Feb;
208:52-8.
PMID: 25637704
Drug delivery vehicles are often assessed for their ability to control primary tumor growth, but the outcome of cancer treatment depends on controlling or inhibiting metastasis. Therefore, we studied the...
8.
The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow
Thompson A, Mastria E, Eniola-Adefeso O
Biomaterials
. 2013 May;
34(23):5863-71.
PMID: 23642534
Particle shape is becoming increasingly recognized as an important parameter for the development of vascular-targeted carriers (VTCs) for disease treatment and diagnosis. However, limited research exists that investigates how particle...
9.
Heslinga M, Mastria E, Eniola-Adefeso O
J Control Release
. 2009 May;
138(3):235-42.
PMID: 19467275
Particle shape, in addition to size, is becoming increasingly recognized as important in the design of drug carriers for in vivo use. However, few methods exist for fabricating non-spherical particles...